Clinical Trials
5
Active:0
Completed:4
Trial Phases
2 Phases
Phase 3:1
Not Applicable:2
Drug Approvals
48
CIMA_AEMPS:26
EMA:22
Drug Approvals
Sitagliptin / Metformin hydrochloride Mylan
- Authorization Status
- Authorised
- Approval Date
- Feb 16, 2022
EMA
Clopidogrel / Acetylsalicylic acid Viatris (previously Clopidogrel / Acetylsalicylic acid Mylan)
- Authorization Status
- Authorised
- Approval Date
- Jan 9, 2020
EMA
Clopidogrel / Acetylsalicylic acid Viatris (previously Clopidogrel / Acetylsalicylic acid Mylan)
- Authorization Status
- Authorised
- Approval Date
- Jan 9, 2020
EMA
- Prev
- 1
- 2
- 3
- Next
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Not Applicable
2 (66.7%)Phase 3
1 (33.3%)A Bioequivalence Study Using Clinical Endpoint for Diclofenac Sodium Gel 1% in Osteoarthritis Knee"
Phase 3
Completed
- Conditions
- Osteoarthritis, Knee
- Interventions
- First Posted Date
- 2017-06-01
- Last Posted Date
- 2022-03-03
- Lead Sponsor
- Mylan Pharmaceuticals Private Limited
- Target Recruit Count
- 1220
- Registration Number
- NCT03172780
- Locations
- 🇮🇳
Yashoda Hospital - Malakpet, Hyderabad, Andhra Pradesh, India
🇮🇳Yashoda Hospital -Secunderabad, Secunderabad, Andhra Pradesh, India
🇮🇳Yashoda Hospital -Somajiguda, Somajiguda, Andhra Pradesh, India
News
No news found